Loading...

CannBioRx Life Sciences Corp.

ATNFW•NASDAQ
Healthcare
Medical - Pharmaceuticals
$0.01
$0.002(16.35%)

CannBioRx Life Sciences Corp. (ATNFW) Company Profile & Overview

Explore CannBioRx Life Sciences Corp.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

CannBioRx Life Sciences Corp. (ATNFW) Company Profile & Overview

180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.

SectorHealthcare
IndustryMedical - Pharmaceuticals
CEOLloyd Blair Jordan

Contact Information

http://www.180lifesciences.com
650 507 0669
Building 4, Palo Alto, DE, 94306

Company Facts

4 Employees
CountryUS
Actively Trading

Frequently Asked Questions

;